Fifty eyes of fifty patients with ocular hypertension had their visual fields tested on a Friedmann Mark 1 field ana lyser whilst wearing a Wratten 47B blue filter in a spec tacle frame. All had normal visual fields to a white stimulus. Use of a scoring system with the blue field iden tified 11 patients (22 %) with ocular hypertension as abnormal. The scores from this subgroup were indistin guishable from a group of subjects with early glaucoma tous field loss, whilst the remaining scores were similar to normal subjects. These two subgroups of ocular hyper tensive patients were similar in age and intraocular pres sure. The use of a blue filter in front of the eye may offer a simple test to identify a subgroup of patients with ocular hypertension who are at increased risk of developing field loss.
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Ocular hypertension (OH) is a frequently seen condition in clinical practice. It is characterised by a raised intra ocular pressure (lOP) but without an associated field defect. Longitudinal studies suggest that approximately 10% of patients with OH will later develop field IOSS, I , 2 although reports of conversion to glaucoma range from 3%3 to nearly 36%4
A major clinical challenge is to identify the subgroup of ocular hypertensives who will later develop field defects. This is of some importance because recent work has sug gested that topical treatment can decrease the incidence of glaucomatous damage. 5
The use of a blue filter with Friedmann visual field screening has been previously reported to increase the size and depth of field defects in glaucoma. 6 However, later work employing a suprathreshold technique suggested that a blue stimulus was less practical and less sensitive than a white stimulus' ? Both of these studies used the inbuilt filter in a Friedmann Mark 2 Visual Field Analyser.
We have found that the use of a blue filter mounted in a This report discusses its use in ocular hypertensive sub jects, and its advantages over a white stimulus.
METHODS
Patients were recruited from ophthalmic outpatient clinics at two hospitals. To be eligible for this study, unaided visual acuity had to be 6/18 or better, with a best corrected acuity of at least 6/9. Known diabetics were excluded, as were patients on miotic drops. All patients gave verbal consent after the nature and purpose of this investigation had been explained to them.
Two groups of patients were identified: normal sub jects, i.e. an lOP <21 mmHg with normal optic discs and healthy fundi and ocular hypertensives with an lOP >21 mmHg without field defects on standard Friedmann test ing or pathological disc changes on biomicroscopy with either a fundal contact lens or a Volk 90 dioptre lens. There were no media opacities on clinical examination.
For all patients, lOPs were recorded using a standard Goldmann applanation tonometer. The diagnostic lOPs (i.e. those recorded before treatment was commenced)
were used in the statistical analysis.
Two visual fields were recorded for each patient, using the Friedmann Mark 1 Visual Field Analyser. The back ground illumination of this machine is in the mesopic range. The protocol is described in detail elsewhere. 8 Briefly, subjects were tested without spectacle correction and the threshold to a white stimulus was determined. This was defined as the filter setting when two of the four tar gets 2.5 degrees from fixation were seen in two of the three attempts allowed. This value was then reduced by 0.4 log units to give the working value. The field to a white stimu lus was then measured at the working value. Any points that were missed after three attempts at this level were re-tested with the neutral density filter being reduced in steps of 0.2 log units, until the targets were seen, or the limits of the machine were reached.
The second visual field was recorded with the subject wearing a spectacle frame containing a Wratten 47B blue filter with an occluder in front of the fellow eye. This filter gives a peak transmission at 440 nanometres. The same sequence as above was employed, although the test was started using the working value already determined for the white target.
A scoring system was used with the blue field, termed the selective blue field (SBF). The highest filter setting for each target setting (groups of 2 to 4 targets) was defined as the threshold for that particular group. One point was then
given for each 0.2 log unit reduction from this derived 'set ting threshold' for the remaining points in the group, to
give the SBF score (see example in Figure 1 ). A similar scoring system was also used with the white field.
Statistical analysis was performed with the unpaired t-test on normally distributed data. Non-parametric tests were employed with the white and SBF scores, which
were not distributed in a normal fashion. Results are given as mean (SD) unless otherwise noted. If both eyes were eligible for inclusion, only one was randomly selected for statistical analysis.
RESULTS
One hundred patients were studied, 50 normal subjects The mean lOP of the normal subjects was, as expected, lower than the OH group (p<O.OOOl). There was no difference in white field score between the normal and ocular hypertensive groups, by definition. The SBF score for normal subjects was significantly lower than the OH group (p>0.02).
There was no difference in macular thresholds between the two groups, and so the operating range of the machine was the same for all. This was not affected by the blue fil ter, because it was used at the working value calculated for the white stimulus. Thirty-six normals and 37 ocular hypertensives had both eyes tested. Paired analysis between right and left eyes (right eyes being tested first throughout) showed no differences in white and SBF
scores.
An upper limit of normal (ULN) of 19.7 was calculated from the SBF scores of normal subjects, in order to give a specificity of 96% Applying this cut-off value to the OH group produces a low OH subgroup of 39 subjects and a high OH subgroup of 11 subjects. The number of ocular hypertensives who fall in the high OH subgroup is unlikely to have arisen by chance (chi squared with Yates'
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'\�/!J \�:-���::/ �� The white field scores show no difference between the low OH and normal groups, whilst the high OH subgroup is just different from both normals and the low OH sub group (p<0.05). There is no difference in SBF score between normals and the low OH group. However, the SBF scores of the high OH and normal subjects are signifi cantly different (p<O.OOOl).
DISCUSSION
In order to perform statistical analysis on visual field data, a scoring system is required. Our system, giving one point for each 0.2 log unit reduction from the working value, is very similar to that used by Henson and co-workers (9,1 0).
Although it gives a better indication of the depth of the defect, our system includes no attempt to weight the scor ing system for clusters of missed points. Despite this, our system gives good discrimination between normal and early glaucoma subjects 8 for both white and blue fields.
However, some of our early glaucoma subjects had an SBF score that was less than the calculated ULN. Dif fering mechanisms of damage have been suggested to occur in glaucoma, supported by a study comparing the blue colour mechanism in low and high tension glau coma. However, the lack of any significant difference in the mean lOPs of the two subgroups would suggest that in fact it played no part. Interestingly, we did not find a correla tion between SBF score and lOP in either group.
The low OH subgroup produced by use of the SBF score with a calculated ULN have similar SBF scores to normal subjects, whereas the high OH subgroup are indis tinguishable from the results that we have previously reported in an early glaucoma group.s The proportion of OH subjects with an abnormal SBF score changes only slightly (from 22% to 26%) when the specificity of the test is reduced from 96% to 90%. A recent study, using a blue stimulus on a yellow background, also found that 19% of ocular hypertensives had glaucomatous field defects that were not present to a white target. 19 However, Sample and Weinreb reported that almost 43% of ocular hypertensives fell more than two standard deviations below normal when measuring the threshold to a blue stimulus on a yellow background. 20 Contrast sensitivity has been shown to be abnormal (defined as greater than 2 SDs from age matched normals) in 63% of subjects with OH/' and pat tern electroretinography has also identified 63% of ocular hypertensives as being abnormal,22 with results in that subgroup being similar to those obtained from patients with early glaucoma. All of these latter proportions are somewhat greater than the reported incidence of conver sion to glaucoma in longitudinal studies of ocular hyper tension.'A However, recent work using peripheral colour contrast sensitivity23 found that about 20% of the high risk OH group were abnormal when using their criteria for glaucomatous subjects.
The visual fields were tested without spectacle correc tion. This was to prevent artefacts arising from the overlap between the sUbject's own spectacle frame and that of the blue filter. This may be a source of error in our results. A recent study has found that topical timolol reduces the incidence of glaucomatous field loss in patients with moderate risk ocular hypertension, based on factors such as lOP and vertical cup-disc ratio.s Their patients had similar lOPs to those in our OH group and its subgroups.
Another group of investigators has also demonstrated this effect,32 although their study population had lower lOPs than our OH group.
Our simple adaptation to the Friedmann protocol may permit recognition of a subgroup of ocular hypertensives who will later develop glaucomatous field loss, and who should benefit from early treatment. However, longitudi nal studies using automated threshold analysers are required to define the value of the use of the blue filter.
